Rare diseases

Sharing the mission to conquer rare diseases

Closer collaboration between pharmaceutical companies and patient organizations will accelerate drug development At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases. Advocacy groups rely on their partners for financial and scientific support while providing access to repositories of patient data – the key to understanding rare diseases …

biopharma, biopharmaindia, india, manufacturing, cellculture, culture medium, media, media preparation, single-use, single-use technology, processing trends, biopharmaceutical processing, biopharmaceutical

Download: Powder Culture Media Packaging, Preparation and Market Trends

This whitepaper from Thermo Fisher reviews the impact from recent trends in biopharmaceutical processing on the usage of culture media and its packaging. Current media preparation problems, future trends, and alternatives to media prep practices are discussed. The findings and commentary from on-line survey of 24 large-scale culture media end-users together with in-depth phone interviews are presented to evaluate relevant …

Top scale up and scale down strategies for cell culture bioreactors

Would you like to know the optimal design for your agitated bioreactor? At the 2012 Cell Culture World Congress Dr Alvin Nienow, Emeritus Professor of Biochemical Engineering at the University of Birmingham delivered a presentation where he looked at Scale-up/scale-down strategies for the production of biopharmaceuticals from animal cell culture in large-scale stirred bioreactors  by evaluating, through physical and biological …

Key Figures and Top Rankings in the BioPharma Industry

According to EvaluatePharma, there is going to be some reshuffling of the top pharma rankings . It is estimated that in 2018, Novartis will be overtaking Pfizer as the top pharmaceutical company (ranked by prescription-drug revenue), with Sanofi coming in third position. Runner-ups include GlaxoSmithKline, Roche and Merck & Co. respectively. The top 6 pharmas are estimated to enjoy sales …

Released: Annual Asian Biopharmaceutical Industry Report

1600 industry professionals shared views about their opinions and interests in Asia’s biopharma industry. In the report, we discovered that partnering with local Asian and global Asian pharmas and biotechs continues to be the top area of interest and concern for the Asian biopharmaceutical industry. The report gave us a glimpse of the heartbeat of the biopharmaceutical industry as all …

Personalized Medicine – The Future of Modern Day Medicine

As the world prepares itself for a consumer-centric economy, it is no wonder that healthcare is catching up with this trend. The increasing hype for personalized medicine cannot be undermined as modern day healthcare demands for a more patient-centric approach. The question remains: Is it hype or hope? According to the Journal of Translational Medicine, personalized medicine is not just …

Strategic R&D Partnerships For Global Competitiveness

Pharma giants face immense challenges as old business models become obsolete, key drugs patents expire, and not to mention the large amounts of capital inlay into drug development. Concurrently, Biotechs struggle to keep up with the competition against these pharma giants. The great news is that pharma giants like Pfizer are now considering to partner Biotech companies to undertake the …